US Global Investors Funds’s Elevance Health ELV Stock Holding History

US Global Investors Funds’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$249K	Buy	+2,700	New	+$240K	0.04%	222

Other funds holding ELV

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

US Global Investors Funds's ELV Position: Q4 2013 in Review

US Global Investors Funds opened a new position in Elevance Health (ELV) in Q4 2013: 2,700 shares worth $249K. The stake represents 0.04% of the portfolio and ranks #222 among its holdings.

640 funds tracked by Wall St. Rank hold ELV as of Q4 2013.

US Global Investors Funds held 2,700 shares of Elevance Health worth $249K as of Q4 2013.
Elevance Health was a new US Global Investors Funds position in Q4 2013.
Elevance Health made up 0.04% of US Global Investors Funds's portfolio in Q4 2013, its #222 holding.
640 funds tracked by Wall St. Rank held Elevance Health as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.